171 related articles for article (PubMed ID: 15830800)
1. [Treatment of Chagas disease with benznidazole and thioctic acid].
Roldán EJ
Medicina (B Aires); 2005; 65(1):85-6; author reply 86-7. PubMed ID: 15830800
[No Abstract] [Full Text] [Related]
2. [Treatment of Chagas disease with benznidazole and thioctic acid].
Sosa-Estani S; Armenti A; Araujo G; Viotti R; Lococo B; Ruiz Vera B; Vigliano C; de Rissio AM; Segura EL
Medicina (B Aires); 2004; 64(1):1-6. PubMed ID: 15034949
[TBL] [Abstract][Full Text] [Related]
3. [Thioctic acid in the prevention of the toxic effects of benznidazole].
Pérez Lloret A; Roldán EJ
Medicina (B Aires); 1984; 44(1):108. PubMed ID: 6443012
[No Abstract] [Full Text] [Related]
4. Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease.
Alvarez MG; Vigliano C; Lococo B; Petti M; Bertocchi G; Viotti R
Trans R Soc Trop Med Hyg; 2012 Oct; 106(10):636-8. PubMed ID: 22898619
[TBL] [Abstract][Full Text] [Related]
5. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
[TBL] [Abstract][Full Text] [Related]
6. [Use of thioctic acid for prevention of the adverse effects induced by benznidazole in patients with chronic Chagas' infection].
Carpintero DJ
Medicina (B Aires); 1983; 43(3):285-90. PubMed ID: 6423926
[No Abstract] [Full Text] [Related]
7. Chagas' disease.
Montero A; Giovannoni AG
Lancet; 2001 Jul; 358(9275):74. PubMed ID: 11458940
[No Abstract] [Full Text] [Related]
8. Adverse events after the use of benznidazole in infants and children with Chagas disease.
Altcheh J; Moscatelli G; Moroni S; Garcia-Bournissen F; Freilij H
Pediatrics; 2011 Jan; 127(1):e212-8. PubMed ID: 21173000
[TBL] [Abstract][Full Text] [Related]
9. [Chagas' disease: clastogenic effect of nifurtimox and benznidazole in children].
Moya PR; Trombotto GT
Medicina (B Aires); 1988; 48(5):487-91. PubMed ID: 3151216
[No Abstract] [Full Text] [Related]
10. Antitrypanosomal agents: treatment or threat?
Issa VS; Bocchi EA
Lancet; 2010 Sep; 376(9743):768; author reply 768-9. PubMed ID: 20816538
[No Abstract] [Full Text] [Related]
11. Potential new clinical therapies for Chagas disease.
Bustamante JM; Tarleton RL
Expert Rev Clin Pharmacol; 2014 May; 7(3):317-25. PubMed ID: 24716790
[TBL] [Abstract][Full Text] [Related]
12. Heart rate variability in chronic Chagas patients before and after treatment with benznidazole.
Oliveira LF; Silva VJ; Lages-Silva E; Molina RJ; Fuzissaki J; Niederhaur S; Prata A; Correia D
Auton Neurosci; 2010 Dec; 158(1-2):118-22. PubMed ID: 20558113
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Chagas disease].
Abitbol H
An R Acad Nac Med (Madr); 1981; 98(4):755-8. PubMed ID: 6808853
[No Abstract] [Full Text] [Related]
14. Should benznidazole be used in chronic Chagas' disease?
Bestetti RB
Lancet; 1997 Mar; 349(9052):653. PubMed ID: 9057760
[No Abstract] [Full Text] [Related]
15. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country.
Carrilero B; Murcia L; Martínez-Lage L; Segovia M
Rev Esp Quimioter; 2011 Sep; 24(3):123-6. PubMed ID: 21947093
[TBL] [Abstract][Full Text] [Related]
16. [Adverse reactions in Chagas disease patients treated with benznidazole, in the State of Ceará].
de Pontes VM; Souza Júnior AS; Cruz FM; Coelho HL; Dias AT; Coêlho IC; Oliveira Mde F
Rev Soc Bras Med Trop; 2010; 43(2):182-7. PubMed ID: 20464150
[TBL] [Abstract][Full Text] [Related]
17. [Allopurinol in the treatment of chronic Chagas' disease].
Meirovich CI; Montrull HL; Gallerano RH; Sosa RR
Arq Bras Cardiol; 1985 Sep; 45(3):217-23. PubMed ID: 3939099
[No Abstract] [Full Text] [Related]
18. Benznidazole for the treatment of Chagas disease.
Losada Galván I; Alonso-Padilla J; Cortés-Serra N; Alonso-Vega C; Gascón J; Pinazo MJ
Expert Rev Anti Infect Ther; 2021 May; 19(5):547-556. PubMed ID: 33043726
[TBL] [Abstract][Full Text] [Related]
19. Low Incidence of Adverse Effects Using a Progressive Regimen of Benznidazole in Chagas Disease.
Navarrete MN; Gutiérrez-Gutiérrez B; de Arellano-Ramos R; Del Castillo SF; Domínguez-Castellano Á
Clin Infect Dis; 2016 Apr; 62(8):1052. PubMed ID: 26769725
[No Abstract] [Full Text] [Related]
20. Does Progressive Introduction of Benznidazole Reduce the Chance of Adverse Events in the Treatment of Chagas Disease?
Losada Galván I; Madrid Pascual O; Herrero-Martínez JM; Pérez-Ayala A; Lizasoain Hernández M
Am J Trop Med Hyg; 2019 Jun; 100(6):1477-1481. PubMed ID: 30938285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
